Global /India /Healthcare /Drug Manufacturers - General /523620
chevron_leftBack
Phaarmasia Ltd. logo

Phaarmasia Ltd.

523620
BSE: 523620 Delayed
93.49INR -5%
0.9902 USD
As of 20 June 2026, Phaarmasia Ltd. has a market cap of $7.1M USD, ranking #42999 globally and #3571 in India. It ranks #3802 in the Healthcare sector, and #1230 in the Drug Manufacturers - General industry.
Global Rank
42999
Country Rank
3571
Sector Rank
3802
Industry Rank
1230
Key Stats
Market Cap
$7.1MUSD
670.13M INR
Enterprise Value
$7.05MUSD
665.83M INR
Revenue (TTM)
$4.76MUSD
449.06M INR
EBITDA (TTM)
$287.67KUSD
27.16M INR
Net Income (TTM)
$1.88MUSD
177.54M INR
EBITDA Margin
6%
Profit Margin
40%
PE Ratio
3.8
PS Ratio
1.5
PB Ratio
6.2
EV/EBITDA
24.5
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Yallapragada Naga Rao open_in_new
Employees
36
Founded
1981
Website
phaarmasia.in open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
-5% -14% 25% -6.5% 174% 204%

News

Loading...

Markets

Exchange Ticker Price
Bombay Stock Exchange
MIC: XBOM
PRIMARY
523620 (PHRMASI)
Phaarmasia Ltd
ISIN: INE486I01016
Shares Out.:
6.827M1
TV:
SA:
YF:
GF:
BA:
MS:
93.49 INR
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About Phaarmasia Ltd.

Phaarmasia Limited manufactures and sells oral contraceptive pills and iron tablets in India. It offers hormone products, including mifepristone and misoprostaol, desogestrel and ethinyl estradiol, estradiol valerate, levonorgestrel and ethinyl estradiol, medroxyprogesterone acetate, cabergoline, clomiphene citrate, levonorgestrel, progesterone, fluoxymesterone, liothyronine sodium, chlorodehydromethyltestosterone, liothyronine sodium, oxandrolone tablets, testosterone cypionate, methenolone enanthate, drostanolone, testosterone, trenbolone, and stanozolol cypionate injections. The company provides herbal products, such as herbal toothpaste, cough and sore throat reliver, and mouth ulcer gel under the Smyle brand name. Phaarmasia Limited was incorporated in 1981 and is based in Hyderabad, India.

Similar Companies

Industry: Drug Manufacturers - General (India)
Name
Market Cap diff.
PE
$45.22B
4.27T INR
637K%
39.1
DIVISLAB
$18.38B
1.73T INR
259K%
70.0
$15.17B
1.43T INR
214K%
63.0
$11.73B
1.11T INR
165K%
19.6
MANKIND
$9.87B
931.67B INR
139K%
52.2
ZYDUSLIFE
$9.71B
916.53B INR
137K%
18.6
Industry: Drug Manufacturers - General (Global)
Name
Market Cap diff.
PE
LLY
$761.68B
11M%
38.1
JNJ
$547.28B
8M%
26.4
ABBV
$360.63B
5M%
97.4
$318.3B
256.25B CHF
4M%
19.9
AZN
$284.64B
215.59B GBP
4M%
27.6
MRK
$274.03B
4M%
15.1
chevron_leftBack